MedTrace Logo

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

NCT04262609 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-03-19

No results posted yet for this study

Summary

The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.

Conditions

Interventions

RADIATION

hypofractionated radiotherapy

volumetric modulated moderately fractionated arc therapy

Sponsors & Collaborators

  • Consorci Sanitari de Terrassa

    lead OTHER

Principal Investigators

  • Joan Lozano, MD · Consorci Sanitari de Terrassa

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2026-02-01
Completion
2026-12-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04262609 on ClinicalTrials.gov